Literature DB >> 8746809

Down-regulation of brain muscarinic cholinergic receptor promoted by diacylglycerols and phorbol ester.

M F Pediconi1, F J Barrantes.   

Abstract

Sustained agonist stimulation induces an asymmetric down-regulation of brain muscarinic acetylcholine receptor (mAChR): 43 +/- 2% in the right and 26 +/- 2% in the left cerebral hemisphere, respectively (Ref. 1). In order to determine the possible involvement of endogenous diacylglycerols produced under muscarinic stimulation in the down-regulation phenomenon, here we have studied the effects of synthetic diacylglycerols and a phorbol ester on cells dissociated from rat cerebral cortex. Oleylacetylglycerol decreased the amount of cell-surface mAChR by 37 +/- 2% and 25 +/- 2% in right and left cerebral cortex, respectively. Long-term treatment with phorbol dibutyrate also produced internalization of the mAChR (25 +/- 1.5% and 33 +/- 2% in right and left cortical cells, respectively). These changes occurred without modification of the Kdapp for the selective antagonist pirenzepine. The action of calcium ions was also studied using incubation of cells with the ionophore A23187. No changes were observed in the amount of mAChR detected at the plasma membrane with the ionophore alone, but when used in combination with phorbol dibutyrate and the agonist carbamylcholine a sinergistic decrease in mAChR was apparent. It is concluded that long-term exposure to exogenously added diacyglycerols and phorbol ester significantly reduces the amount of mAChR detected at the plasma membrane and abolishes the asymmetry of the down-regulation phenomenon observed under specific muscarinic stimulation, suggesting that diacylglycerols may be one of the factors responsible for such asymmetry.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8746809     DOI: 10.1007/bf00995387

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  33 in total

Review 1.  Regulation of protein kinase C activity by various lipids.

Authors:  A A Farooqui; T Farooqui; A J Yates; L A Horrocks
Journal:  Neurochem Res       Date:  1988-06       Impact factor: 3.996

Review 2.  The molecular basis of muscarinic receptor diversity.

Authors:  T I Bonner
Journal:  Trends Neurosci       Date:  1989-04       Impact factor: 13.837

3.  Activation of protein kinase C induces rapid internalization and subsequent degradation of muscarinic acetylcholine receptors in neuroblastoma cells.

Authors:  W C Liles; D D Hunter; K E Meier; N M Nathanson
Journal:  J Biol Chem       Date:  1986-04-25       Impact factor: 5.157

4.  Dioctanoylglycerol and phorbol diesters enhance phosphorylation of phosphoprotein B-50 in native synaptic plasma membranes.

Authors:  J Eichberg; P N de Graan; L H Schrama; W H Gispen
Journal:  Biochem Biophys Res Commun       Date:  1986-05-14       Impact factor: 3.575

Review 5.  Studying neurotransmitter receptors: binding and biological assays.

Authors:  E Richelson
Journal:  Monogr Neural Sci       Date:  1984

Review 6.  Regulation of transmembrane signaling by receptor phosphorylation.

Authors:  D R Sibley; J L Benovic; M G Caron; R J Lefkowitz
Journal:  Cell       Date:  1987-03-27       Impact factor: 41.582

7.  Agonist regulation of muscarinic acetylcholine receptors in rat spinal cord.

Authors:  J E Taylor; T L Yaksh; E Richelson
Journal:  J Neurochem       Date:  1982-08       Impact factor: 5.372

8.  Enhancement of the muscarinic synaptosomal phospholipid labeling effect by the ionophore A23187.

Authors:  S K Fisher; B W Agranoff
Journal:  J Neurochem       Date:  1981-10       Impact factor: 5.372

9.  Differential receptor occupancy requirements for muscarinic cholinergic stimulation of inositol lipid hydrolysis in brain and in neuroblastomas.

Authors:  S K Fisher; R M Snider
Journal:  Mol Pharmacol       Date:  1987-07       Impact factor: 4.436

Review 10.  Neuronal muscarinic responses: role of protein kinase C.

Authors:  E E el-Fakahany; B E Alger; W S Lai; T A Pitler; P F Worley; J M Baraban
Journal:  FASEB J       Date:  1988-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.